Xylem Inc. $XYL Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its stake in shares of Xylem Inc. (NYSE:XYL) by 1.2% during the 3rd quarter, Holdings Channel.com reports. The firm owned 1,366,117 shares of the industrial products company’s stock after selling 17,104 shares during the period. Bank of New York Mellon Corp’s holdings in Xylem were worth $201,502,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Ballentine Partners LLC grew its position in shares of Xylem by 7.4% during the third quarter. Ballentine Partners LLC now owns 17,031 shares of the industrial products company’s stock worth $2,512,000 after buying an additional 1,170 shares in the last quarter. Federated Hermes Inc. lifted its stake in Xylem by 1.2% in the third quarter. Federated Hermes Inc. now owns 313,990 shares of the industrial products company’s stock worth $46,314,000 after acquiring an additional 3,726 shares during the last quarter. J. Safra Sarasin Holding AG grew its holdings in Xylem by 187.9% during the 3rd quarter. J. Safra Sarasin Holding AG now owns 327,467 shares of the industrial products company’s stock worth $48,301,000 after acquiring an additional 213,731 shares in the last quarter. Phoenix Financial Ltd. acquired a new position in Xylem during the 3rd quarter worth approximately $592,000. Finally, National Wealth Management Group LLC acquired a new stake in shares of Xylem in the 3rd quarter valued at $577,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Insiders Place Their Bets

In other Xylem news, Director Victoria D. Harker sold 1,700 shares of the firm’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the transaction, the director directly owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. This trade represents a 9.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.27% of the stock is currently owned by corporate insiders.

Xylem Stock Down 0.0%

Xylem stock opened at $137.89 on Friday. The company has a market capitalization of $33.57 billion, a P/E ratio of 35.45, a PEG ratio of 1.96 and a beta of 1.17. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.50 and a current ratio of 1.96. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $154.27. The stock has a 50-day simple moving average of $139.60 and a 200-day simple moving average of $141.74.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The company had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. During the same quarter in the previous year, the company posted $1.11 earnings per share. The firm’s revenue was up 7.8% compared to the same quarter last year. Equities research analysts expect that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 23rd. Investors of record on Tuesday, November 25th were given a $0.40 dividend. The ex-dividend date was Tuesday, November 25th. This represents a $1.60 annualized dividend and a yield of 1.2%. Xylem’s dividend payout ratio is 41.13%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Barclays decreased their price objective on shares of Xylem from $172.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday, January 7th. Mizuho lowered their price objective on Xylem from $160.00 to $150.00 and set a “neutral” rating for the company in a research report on Monday, January 5th. Zacks Research downgraded Xylem from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Wall Street Zen cut Xylem from a “buy” rating to a “hold” rating in a research note on Saturday, December 27th. Finally, Citigroup increased their price target on shares of Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Nine equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $165.80.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.